Eastman Chemical (EMN) EBT (2009 - 2026)

Eastman Chemical (EMN) has reported EBT for 18 consecutive years, with $311.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 40.09% year-over-year to $311.0 million; the trailing twelve-month figure through Jun 2026 stood at $751.0 million (down 37.52% YoY), and the FY2025 full-year result was $776.0 million, down 39.28% from the prior year.
• EBT grew to $311.0 million in Q2 2026 per EMN's latest filing, from $188.0 million in the prior quarter.
• Across five years, EBT topped out at $477.0 million in Q4 2023 and bottomed at $64.0 million in Q4 2025.
• Historically, EBT has averaged $278.6 million across 5 years, with a median of $306.5 million in 2025.
• The sharpest annual moves came in 2022 and 2023: EBT sank 86.85% in 2022, then surged 527.63% in 2023.
• Over 5 years, EBT stood at $76.0 million in 2022, then soared by 527.63% to $477.0 million in 2023, then fell by 26.83% to $349.0 million in 2024, then slumped by 81.66% to $64.0 million in 2025, then surged by 385.94% to $311.0 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $311.0 million, $188.0 million, and $64.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.